Cypress Associates LLC is pleased to announce the completion of the sale of Urology of Indiana’s radiation assets to a new company jointly owned by Urology of Indiana, LLC (UOI) and Vantage Oncology, LLC (Vantage). As a result of the transaction, UOI and Vantage plan to grow high quality radiation therapy services in the state of Indiana through a combination of strategic insight, application of clinical best- practices and a patient centered approach.

Urology of Indiana, LLC is the largest urology practice in greater Indianapolis and is a leading provider of radiation therapy treatment in the state of Indiana through its two Centers for Prostate Cancer (CPCs). UOI has operated CPCs in Indianapolis since 2006 and provides a comfortable experience to prostate cancer patients while delivering the highest quality of care. Prior to the transaction, the CPCs were wholly owned by UOI.

Founded in 2002, Vantage Oncology, LLC develops and operates radiation oncology centers of excellence through acquisitions and joint ventures. The company seeks to address the growing need among cancer patients, hospitals and physicians for easily accessible and advanced radiation treatment therapies. Vantage Oncology currently operates 63 treatment facilities in 15 states.

As a result of the transaction, UOI and Vantage plan to grow high quality radiation therapy services in the state of Indiana through a combination of strategic insight, application of clinical best- practices and a patient centered approach. Cypress Associates LLC acted as financial advisor to UOI in the sale of its radiation assets to a new company jointly owned by UOI and Vantage.